SM

Sam J. Milstein

Chairman at Cerus Endovascular

Sam J. Milstein has been in the healthcare industry in various capacities for over 40 years. He has extensive experience in every aspect of the drug discovery and development process and has served as a consultant to the pharmaceutical and biotech industry, Wall Street, and venture capital communities. He has founded several companies. He is the Founder and CEO of Mortar & Pestle Consulting.

Dr. Milstein was the Founder, Chief Executive Officer, Chief Science Officer, and Chairman of Fulcrum Pharmaceuticals, Inc. Previously, he was the President and Chief Science Officer at Emisphere Technologies, Inc.. Dr. Milstein was an Adjunct Professor of Biochemistry at New York University. Dr. Milstein is on the Board of Directors of the Regenerative Medicine Foundation. Dr. Milstein holds numerous patents on Physico-Chemical Mechanisms for drug delivery. He holds a Ph.D. in Biochemistry from New York University, an M.Sc. in Physical Chemistry from the University of New Brunswick, and majored in Chemistry from the City College of New York.

Timeline

  • Chairman

    Current role